Document is current
Any future updates will be listed below
-
Authors
Ma, Si-Cong
Bai, Xue
Guo, Xue-Jun
Liu, Li
Xiao, Lu-Shan
Lin, Yan
Tan, Jia-Le
Cai, Xiao-Ting
Wen, Yu-Xiang
Ma, Hu
Fu, Q. John
Leng, Meng-Xin
Zhang, Yan-Pei
Long, Li-Li
Guo, Ze-Qin
Wu, De-Hua
Zhou, Jian-Guo
Dong, Zhong-Yi http://orcid.org/0000-0001-9967-0060
-
Funding
Funding for this research was provided by:
National Natural Science Foundation for Young Scientists of China (81802863)
National Natural Science Foundation of China (81773008, 81972897)
Natural Science Foundation of Guangdong Province (2018030310285)
Clinical Research Startup Program of Southern Medical University by High-level University Construction Funding of Guangdong Provincial Department of Education (LC2019ZD003)
Outstanding Youths Development Scheme of Nanfang Hospital, Southern Medical University (2020J011)
- License Information
-
More Information
Article History
Received: 4 December 2021
Accepted: 24 February 2022
First Online: 12 April 2022
Declarations
:
: The study was approved by the Institutional Ethical Review Boards of Nanfang Hospital. All patients enrolled in OAK, FIR, and BIRCH provided signed informed consent in accordance with the protocols of the corresponding studies. Deidentified individual-participant data of the three clinical trials were accessed according to Roche’s policy and process for clinical study data sharing.
: All authors agreed on the publication of the manuscript.
: The authors have no actual or potential conflicts of interest to declare.
